No Picture
News

Biopharma companies pledge $1B to fund antibiotics R&D as field shrivels; Four biotechs hunt $797M+

? As promised, a group of some 20 biopharma companies have pooled close to $1 billion to fund new research in antibiotics — a field that has been dying of late. Small margins and tiny markets have killed off a slate of players in the field and drove ou… […]

No Picture
News

Zai Lab inks China deal with Turning Point with $25M upfront; Xencor, Atreca team up on bispecifics

? Zai Lab is paying out a $25 million upfront for the rights to sell Turning Point Therapeutics’ lead drug repotrectinib in Greater China. The San Diego-based biotech is also in line for up to $151 million in milestones, along with mid-to-high teen roy… […]

No Picture
News

CEND Therapeutics Announces Board Member David Slack Will Succeed Erkki Ruoshlahti as President & CEO

LA JOLLA, Calif., July 08, 2020 (GLOBE NEWSWIRE) — Cend Therapeutics, Inc. (formerly DrugCendR, Inc.), a clinical-stage biotech company, announced today changes in the senior management of the company. David Slack, MBA will take over as President an… […]